Lower risk Drug recall · FDA · Published November 27, 2018

Glenmark Aprepitant Capsules 40mg Recall: Missing Capsule in Blister Pack

Glenmark recalls Aprepitant 40mg capsules due to customer reports of missing capsules in blister packs. Affected units have specific NDC and lot numbers. Consumers should check their packaging for the recall details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0349-2019Drug Glenmark ›

Lower-risk recall

Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.

Take action

Contact the company

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009

✎ GovInfoNow plain-language explainer

Glenmark is recalling Aprepitant 40mg capsules because some blister packs contain missing capsules. This could lead to incorrect dosing if a patient takes fewer capsules than prescribed. Read more at govinfonow.com/recall/39410-glenmark-aprepitant-capsules-40mg-recall-missing-capsule-in-blister-pack.

Source Summary by GovInfoNow · govinfonow.com/recall/39410-glenmark-aprepitant-capsules-40mg-recall-missing-capsule-in-blister-pack · Updated October 5, 2026 · FDA enforcement record: FDA #D-0349-2019

Cite this page

“Glenmark Aprepitant Capsules 40mg Recall: Missing Capsule in Blister Pack.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39410-glenmark-aprepitant-capsules-40mg-recall-missing-capsule-in-blister-pack. Based on FDA recall #D-0349-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0349-2019%22&limit=1).

Glenmark Pharmaceuticals Inc., USA voluntarily recalled Aprepitant Capsules, USP 40 mg due to missing capsules in blister packs, according to the FDA. The Food and Drug Administration announced the Class III recall on Nov. 27, 2018.

How to tell if you have it

Brand: Glenmark
Product: Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only
UPC: 00368462583401
NDC: 68462-583-40
Lot: 17180918
Expiration: June 2020
Quantity: 5,016 blister packs

The hazard

The recall addresses customer reports of missing capsules in the blister pack. The FDA classified the issue as a Class III recall.

Context

GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has 54 other recalls on record since 2017-11-20. Other recent recalls of similar products include Glenmark Azelaic Acid Gel 15% Recall (2026-07-23), Glenmark Alyacen Birth Control Tablets Recall (2026-05-27), and Glenmark Ondansetron Tablets Recall (2025-12-30).

How to tell if you have this one

Check for the NDC 68462-583-40 and lot number 17180918 on the blister pack. The product was manufactured in India and shipped to the US by Glenmark Pharmaceuticals.

Brand
Glenmark
Product
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Packaging
Look for the NDC 68462-583-40 and lot number 17180918 on the blister pack to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

Nov 27, 2018Firm started the recall
Dec 26, 2018Published in FDA’s Enforcement Report
Jan 7, 2019FDA classified it Class III
Sep 12, 2019FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Glenmark recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/39410-glenmark-aprepitant-capsules-40mg-recall-missing-capsule-in-blister-pack">Glenmark Aprepitant Capsules 40mg Recall: Missing Capsule in Blister Pack (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0349-2019 (November 27, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0349-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.